Hypomagnesemia and Diabetic Nephropathy

Hypomagnesemia as a Marker of Diabeteiv Nephropathy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03690180

Enrollment

100

Registered

2018-10-01

Start date

2018-01-01

Completion date

2018-02-28

Last updated

2019-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Nephropathies

Brief summary

To find if there is a corrolatation between Microalbuminurea and diabetic retinopathy, in daibetic patients

Detailed description

40 Daibetic patients with microalbuminurea will be subjeted to full clinical examination and fundus examination,20 control diabetics with out microalbuminurea will also be included for comparison,patients will be selected from the outpatient clinic 0f fayoum university hospital.

Interventions

DIAGNOSTIC_TESTserum magnesium

assessment of serum magnesium in all patients

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diabetics on oral treatment,diabetics on insulin

Exclusion criteria

* Healthy volunteers,,hypertensive patients with normal blood glucose

Design outcomes

Primary

Measure	Time frame	Description
Decrease in serum magnesium	One month	statistical significant change in serum magnesium in diabetics with microalbuminuria

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026